We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-9.64%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$585M
AUM Growth
-$73.1M
Cap. Flow
+$1.63M
Cap. Flow %
0.28%
Top 10 Hldgs %
31.26%
Holding
141
New
43
Increased
25
Reduced
14
Closed
51

Top Buys

Rank Stock Value
1
GRFS
Grifois
GRFS
+$10.6M
2
XENT
Intersect ENT, Inc
XENT
+$6.54M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.92M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$5.92M
5
ESTA icon
Establishment Labs
ESTA
+$5.5M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$10.1M
2
DHR icon
Danaher
DHR
+$7.15M
3
ARQL
Arqule Inc
ARQL
+$6.98M
4
GH icon
Guardant Health
GH
+$6.04M
5
ABBV icon
AbbVie
ABBV
+$5.82M

Sector Composition

Rank Sector Weight
1 Healthcare 39.74%
2 Industrials 1.15%
3 Consumer Staples 0.71%
4 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
26
Gilead Sciences
GILD
$168B
$9.51M 1.62%
150,000
+50,000
+50% +$3.27M
ILMN icon
27
CALL
Illumina
ILMN
$29.1B
$9.13M 1.56%
+30,840
New +$9.09M
SNN icon
28
Smith & Nephew
SNN
$12.6B
$8.66M 1.48%
180,000
-70,000
-28% -$3.22M
CHRS icon
29
CALL
Coherus Oncology
CHRS
$184M
$8.1M 1.38%
+400,000
New +$7.99M
SRPT icon
30
PUT
Sarepta Therapeutics
SRPT
$1.89B
$7.53M 1.29%
+100,000
New +$11.8M
RCM
31
DELISTED
R1 RCM Inc. Common Stock
RCM
$6.76M 1.16%
757,139
+109,998
+17% +$1.3M
DXCM icon
32
DexCom
DXCM
$33.4B
$6.72M 1.15%
180,000
-69,148
-28% -$2.69M
VRAY
33
CALL
DELISTED
ViewRay, Inc.
VRAY
$6.53M 1.11%
2,250,000
+2,150,000
+2,150% +$12.7M
UNH icon
34
PUT
UnitedHealth
UNH
$367B
$6.52M 1.11%
30,000
– –
CGC
35
PUT
Canopy Growth
CGC
$422M
$6.31M 1.08%
+27,500
New +$8.41M
IVC
36
DELISTED
Invacare Corporation
IVC
$6.15M 1.05%
819,874
-109,702
-12% -$615K
KIDS icon
37
OrthoPediatrics
KIDS
$632M
$6.08M 1.04%
172,500
+28,092
+19% +$973K
STAA icon
38
CALL
STAAR Surgical
STAA
$1.25B
$5.96M 1.02%
231,200
+25,000
+12% +$760K
BAX icon
39
Baxter International
BAX
$14.3B
$5.25M 0.9%
60,000
+22,500
+60% +$1.92M
ALXN
40
DELISTED
Alexion Pharmaceuticals
ALXN
$5.14M 0.88%
+52,500
New +$5.92M
MDCO
41
CALL
DELISTED
Medicines Co
MDCO
$5M 0.85%
+100,000
New +$3.99M
INOV
42
CALL
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$4.92M 0.84%
+300,000
New +$4.79M
CNMD icon
43
CONMED
CNMD
$1.5B
$4.57M 0.78%
47,500
-2,500
-5% -$235K
TXG icon
44
10x Genomics
TXG
$7.79B
$4.54M 0.77%
+90,000
New +$4.98M
QTNT
45
DELISTED
Quotient Limited Ordinary Shares
QTNT
$4.39M 0.75%
14,127
+8,660
+158% +$3.34M
ICUI icon
46
CALL
ICU Medical
ICUI
$4.56B
$4.39M 0.75%
27,500
-12,500
-31% -$2.49M
SPPI
47
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$4.15M 0.71%
500,000
– –
GNLN icon
48
Greenlane Holdings
GNLN
$1.21M
– –
0
– –
MRTX
49
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$3.9M 0.67%
+50,000
New +$4.69M
GWPH
50
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.45M 0.59%
+30,000
New +$4.55M
1
2
3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2019 Portfolio in Review

As of Q3 2019, Pura Vida Investments held 141 positions worth $585M, down 11% from $658M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pura Vida Investments's Q3 2019 filing shows 43 new, 25 increased, 14 reduced and 51 closed positions. Its largest new stake was Grifois: 496,201 shares worth $9.94M. The largest sale was Boston Scientific, an estimated $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 45% a quarter earlier, followed by Industrials and Consumer Staples.

  • Pura Vida Investments's largest Q3 2019 buy was Grifois: 496,201 shares worth $9.94M.
  • Pura Vida Investments added most to Intersect ENT, Inc in Q3 2019, an estimated $6.54M increase.
  • Pura Vida Investments's biggest Q3 2019 reduction was Zimmer Biomet, cutting an estimated $5.66M.
  • Pura Vida Investments fully exited Boston Scientific in Q3 2019, selling an estimated $10.1M.
  • Pura Vida Investments's ten largest holdings make up 31% of its $585M portfolio in Q3 2019.
  • Pura Vida Investments opened 43 new positions and closed 51 in Q3 2019.
  • Pura Vida Investments's portfolio value fell 11% quarter-over-quarter to $585M.

Based on Pura Vida Investments's 13F filing for Q3 2019, filed 14 Nov 2019.